ARID1A mutant ovarian clear cell carcinoma: A clear target for synthetic lethal strategies

Biochimica Et Biophysica Acta. Reviews on Cancer
Joseph J CaumannsSteven de Jong

Abstract

SWI/SNF chromatin remodeling complexes play an important role in the epigenetic regulation of chromatin structure and gene transcription. Mutual exclusive subunits in the SWI/SNF complex include the DNA targeting members ARID1A and ARID1B as well as the ATPases SMARCA2 and SMARCA4. SWI/SNF complexes are mutated across many cancer types. The highest mutation incidence is found in ARID1A, primarily consisting of deleterious mutations. Current advances have reported synthetic lethal interactions with the loss of ARID1A in several cancer types. In this review, we discuss targets that are only important for tumor growth in an ARID1A mutant context. We focus on synthetic lethal strategies with ARID1A loss in ovarian clear cell carcinoma, a cancer with the highest ARID1A mutation incidence (46-57%). ARID1A directed lethal strategies that can be exploited clinically include targeting of the DNA repair proteins PARP and ATR, and the epigenetic factors EZH2, HDAC2, HDAC6 and BRD2.

Citations

Nov 17, 2019·International Journal of Molecular Sciences·Pradip De, Nandini Dey
Jan 25, 2020·Annual Review of Pathology·Yemin WangDavid G Huntsman
Jun 6, 2020·International Journal of Environmental Research and Public Health·Yueh-Han HsuAnd Chia-Ming Chang
Jun 27, 2019·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·Zhuandi GongSuocheng Wei
Jun 25, 2020·The Journal of Obstetrics and Gynaecology Research·Aiko OgasawaraKosei Hasegawa
Aug 30, 2019·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Dmitriy Zamarin
Sep 20, 2020·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Yasushi IidaC Simon Herrington
Nov 25, 2020·Genes·Fabian AchenbachNadine T Gaisa
Jun 3, 2021·International Journal of Molecular Sciences·Naoki KawaharaHiroshi Kobayashi
Jun 26, 2021·Journal of Experimental & Clinical Cancer Research : CR·Yali WangYanmei Zou
Aug 14, 2020·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Li WangXiaochun Zhang
Sep 15, 2021·Molecular Cancer Therapeutics·Akshaya Chandrasekaran, Kevin M Elias

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Epigenetics Chromatin Complexes (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin complexes and their role in cancer epigenetics.

Cancer Epigenetics and Chromatin (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin and its role in cancer epigenetics please follow this feed to learn more.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

© 2022 Meta ULC. All rights reserved